IndianWeb2
Home Press Release

Mumbai-based Doxper, a health tech startup which has created a digital pen and coded paper system for doctors to record patient information, has raised $1.1 million (approx Rs 7.3 crore) in a pre-series A round led by existing investor Vidal Healthcare, a health insurance company, reported Economic Times.

Earlier in August 2017, the startup had raised $750,000 in a seed round led by Vidal Healthcare and early-stage investment firm GrowX Ventures. Other investors who participated in that round include Capier Investments and venture capital firm Globevestor.

With this fresh round of funding, the startup has raised a total of $1.9 million.

The startup will use the freshly raised funds to expand its geographical sales presence and to increase its research and development spend for new products in analytics, patient engagement and real-time inter-operability.

Founded in 2015 by Pawan Jain, Randeep Singh and Shailesh Prithani, Doxper allows clinicians to instantly digitise their case sheets using a smart digital pen and encoded paper without the need to change their behaviour. Doxper serves over 800 doctors and clinicians across five cities. The startup’s vision is to make Doxper the de-facto choice for healthcare digitisation in India and other emerging markets.

The startup’s smart device — ‘Doxper’ is a combination of digital pen and paper. Whenever a healthcare practitioner writes something it gets captured automatically which only the doctor and the patient can view, and access their data. With Bluetooth transfer the data is available on mobile. There is cloud storage hence loss of data is minimized. It is a safe a secure environment to safe medical records for both patients and doctors.

Doxper Pen

Patients can use the Doxper app to access their records, book follow-on appointments, and share reports with family. Hospitals can also use Doxper to digitise their records by integrating their Hospital Information System.

Doxper is currently piloting its product in Bangladesh and Nigeria and is actively engaging with partners in the UK, Middle East, Southeast Asia, Brazil and South Africa to start operations by early next year. In India, the company is servicing doctors in Delhi/NCR, Jaipur, Pune, Bangalore and Mumbai.

According to YourStory, Doxper is currently building a real-time and cashless OPD network. The other areas of application and impact the team is looking at include public health (screening, disease registries, disease trends, healthcare supply chain and policy), pharma (real world evidence and CROs), and home healthcare (geriatric care, sample pickups, allied healthcare services).

Earlier this month, an another Maharashtra-based startup Biosense Technologies, which has also built a smart device for healthcare consumption, has raised $1 million in direct equity funding from Menterra Venture along with its investment partner Artha Venture Challenge.

Recent Health Tech Startups’ Fundings

In this month, Bangaluru-based startup PregBuddy, a health-tech startup for women pregnancy, has raised an undisclosed amount in a seed round of funding from Indian Angel Network (IAN).

Last month Karma Healthcare, an Udaipur, Rajasthan-based startup in the technology-led healthcare space, has raised INR 3 crore in equity funding from early stage investment firm 1Crowd.

In January, Sridhar Vembu, founder of Zoho, has announced that he has invested about $10 million in vTitan, a medical device startup based out of Chennai.

Last December, health-tech startup KiViHealth raised $400K funding from Claris Capital and Chandigarh Angels followed by $350,000 seed funding of Kolkata-based EasyBuyHealth.

[Top-most Image – Yourstory.com]

Like this content? Sign up for our daily newsletter to get latest updates.

Every Venture Is Not About Capital !
Independent digital media & Free Press is supported solely by contribution from individuals like you. Unlike other digital media entities in India, IndianWeb2.com do not take a cent from investors or governments, so your contribution makes a big difference and helps us stay independent without any equity to investors --

Comments

comments